Treatment
What treatments do people receive?
-
Counselling continues to be the most common treatment provided
-
2 in 3 treatment episodes were provided in a non-residential setting (such as community-based day programs)
-
Treatment episodes for counselling were longer than all other treatment types (68 days median duration)
Treatment in Australia
Many types of treatment are available in Australia, aiming to reduce the risk of harm associated with drug use through services such as counselling, withdrawal management, rehabilitation, support and case management or information and education. For a subset of people who use alcohol and drugs, treatment and support will be required over the course of their life (consistent with dependence being a chronic condition, like asthma or diabetes). In many cases, people may require ongoing support to achieve long-term change. For other people, early support and treatment will be sufficient to reduce harms and prevent the need for further treatment or they may access treatment intermittently as required (Australian Government Department of Health and Aged Care 2019).
In 2024–25:
- A total of 244,411 treatment episodes were provided to people for their own or someone else’s alcohol or drug use.
- Treatment episode numbers increased by 18% since 2015–16 (206,395) and rose by 1.4% compared to last year (240,958 in 2023–24).
- This could be due to some clients returning for 2 or more episodes of treatment, especially in Victoria, Queensland and the Northern Territory.
- Clients received an average of 1.9 treatment episodes nationally.
What are the treatment types?
In 2024–25:
- Counselling continued to be the most common main treatment type, making up almost one third (32%) of all treatment episodes, followed by assessment only (21%) and support and case management (18%).
- For people receiving treatment for their own alcohol or drug use, one third (33%) of episodes were for counselling and almost one quarter (23%) were for an assessment only, which continues to rise.
- For people who received support for someone else’s drug use, half (50%) of the episodes were for support and case management and about one quarter (24%) were for counselling, which is a decrease from last year (35%) (Figure 1).
Figure 1: Closed treatment episodes, by main treatment type, client type and state and territory, 2015–16 to 2024–25
Stacked bar graph shows number and proportion of treatment episodes by main treatment type from 2015–16 to 2024–25. Data is filtered by client type and state/territory.
Treatment setting
Nationally, in 2024–25:
- 2 in 3 treatment episodes were provided in a non-residential setting (68%), such as community-based day programs and hospital outpatient services.
- The next most common settings included:
- Residential settings (15%) (this setting allows clients to stay in a place that is not their home or usual residence).
- Outreach settings (6.8%) and other settings (6.7%), which can include mobile/outreach drug treatment services (Figure 2).
Figure 2: Closed treatment episodes, by main treatment type, delivery setting and state and territory, 2015–16 to 2024–25
Horizontal stacked bar graph shows the number and proportion of closed treatment episodes by main treatment type and delivery setting from 2015–16 to 2024–25. Data is filtered by year and state/territory.
Length of treatment
In 2024–25, treatment episodes lasted on average 3 and a half weeks (25 days median duration). The length of treatment episodes depended on the main type of treatment and the principal drug of concern:
- For all people who received counselling, treatment episodes lasted for 68 days (median duration).
- For people who received treatment for their own alcohol or drug use, the typical length of treatment was 40 days (median duration) for rehabilitation, 8 days for withdrawal management, and 3 days for an assessment only.
- For the four most common principal drugs of concern, the length of treatment was longest for cannabis (30 days median duration), followed by methamphetamine (29 days), heroin (28 days) and alcohol (27 days).
What are the common reasons for ceasing treatment?
In 2024–25:
- 3 in 5 (59%) of all treatment episodes ended as planned or expected.
- 1 in 5 (19%) of episodes ended unexpectedly (that is, the client ceased to participate against advice, without notice or due to non-compliance).
- 6.7% of episodes ended due to the client being referred onto another service or their type of treatment or drug of concern changed (Figure 3).
Figure 3: Closed treatment episodes, by reason for cessation and main treatment, 2015–16 to 2024–25
Stacked bar graph shows number and proportion of closed treatment episodes by reason for cessation from 2015–16 to 2024–25. Data is filtered by main treatment type.
Australian Government Department of Health and Aged Care 2019. National Framework for Alcohol, Tobacco and Other Drug Treatment 2019–29, Department of Health and Aged Care, Australian Government, accessed 6 March 2024.